NeoVentures Biotechnology Inc

NeoVentures Biotechnology Inc., located at 5 York Street in London, Ontario, is a cutting‑edge technology firm specializing in the discovery and development of aptamers—synthetic DNA or RNA molecules that bind targets with high specificity. As the industry’s pioneer, NeoVentures was the first company to bring an aptamer‑based diagnostic to market, demonstrating its expertise in translating advanced molecular tools into practical healthcare solutions. Leveraging state‑of‑the‑art platforms and a dedicated research team, NeoVentures offers custom aptamer services and innovative diagnostic technologies that give partners a competitive edge in biotech and medical research.